Project Grant HT9425261E166
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) received a $750,000 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded March 1, 2026, with completion scheduled for February 28, 2029. This three-year award supports research and development activities focused on the use of dimeric immunoglobulin A as a therapeutic approach to treat breast cancer. The research will be...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $1,226,730 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2029. The award funds research investigating the canonical Polycomb Repressive Complex 1 (cPRC1) as an intrinsic mechanism of resistance to enzalutamide in advanced prostate cancer. This hypothesis-driven research initiative...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $1.97M Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2028. The award supports the development of CD46-targeted antibody fragment radiopharmaceutical therapy for prostate cancer treatment. This research initiative represents a translational medicine effort to advance diagnostic and...
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) received a $328,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025, through June 30, 2027. The award funds research on intracranial drug delivery strategies targeting skull bone marrow to generate antitumoral myeloid cell immune responses against glioblastoma. This research initiative represents UCSF's...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $1.148 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct research on targeting and imaging vitamin B5 metabolism in diffuse midline gliomas. The award, dated September 1, 2025, with a completion date of August 31, 2028, supports a three-year research initiative focused on developing novel diagnostic and therapeutic...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $1,594,419 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the project "Radiopathomic Mapping of Tumor Burden for Personalized Management of IDH-Mutant Glioma." The award, effective September 1, 2025, through August 31, 2028, supports advanced biomedical research focused on developing innovative diagnostic and...
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) received a $1.23 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2025, with a completion date of September 29, 2029. The award supports research to validate CD46 as a promising biomarker in advanced prostate cancer, aligning with the DHA's mission to transform healthcare for service members and the...
- Federal Project Grant Award Summary The University of California, San Francisco (UCSF) received a $2.72 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 15, 2025, through July 14, 2029. The award supports advanced biomedical research titled "Imaging Cardiac Metabolic Flux and Mitochondrial Function by Hyperpolarized 13C and CEST Metabolic Magnetic Resonance Imaging," which will...
- This federal Project Grant award of $1,041,595.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF) on September 1, 2024. The award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, this 3-year Melanoma Research Program Team Science Award will fund innovative and...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $999,999 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 28, 2025, through September 27, 2028. The award funds research to uncover the relationship between myelin and synapse dynamics in multiple sclerosis. This three-year initiative supports hypothesis-driven biomedical research designed to advance...
The University of California, San Francisco (UCSF) received a $1.62M project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) awarded June 1, 2026, for a three-year performance period concluding May 31, 2029. The award supports research and development activities focused on novel mitochondrial metabolism inhibitors targeting aggressive and treatment-resistant MYC-high breast cancers. This research initiative aligns with the Defense Health Agency's mission to transform healthcare for service members and the American public through innovative biomedical solutions addressing critical health challenges. Under this project grant, UCSF will conduct hypothesis-driven research designed to develop and evaluate therapeutic approaches for breast cancer subtypes that demonstrate aggressive characteristics and resistance to standard treatment modalities. The deliverables include research and development services, biomarker discovery activities, and translational research outputs advancing therapeutic development in oncology. The award reflects UCSF's established capabilities in cancer research and its competitive standing within the Defense Health Agency's portfolio of biomedical research investments.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.6m | 5/22/26 |